Investigated event: Influence on patient derived cell proliferation
| Name | Value |
|---|---|
| Compound | Atiprimod |
| Investigated event | Influence on patient derived cell proliferation |
| Experiment type | MTS |
| Concentration | N/A µM |
| Cell line | expanded erythroid progenitor cells |
| Organism | Homo sapiens |
| Animal model | patient material |
| STAT protein | |
| Other |
Reference
Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer. Oncotarget Karine Pozo, Stefan Zahler, Keisuke Ishimatsu, Angela M Carter, Rahul Telange, Chunfeng Tan, Shuaijun Wang, Roswitha Pfragner, Junya Fujimoto, Elizabeth Gardner Grubbs, Masaya Takahashi, Sarah C Oltmann, James A Bibb, 9, 102, 2018-12-28, 2018-12-28, 10.18632/oncotarget.26480
DOI: 10.18632/oncotarget.26480
PUBMED: 30701022
PMCID: PMC6340867